Extended-spectrum beta lactamase by ceftazidime to ceftazidime clavulanate inhibitory concentration ratio:Imp:Pt:Bld.pos growth:Ord:Based on lab data

Preferred Label : Extended-spectrum beta lactamase by ceftazidime to ceftazidime clavulanate inhibitory concentration ratio:Imp:Pt:Bld.pos growth:Ord:Based on lab data;

LOINC status : ACTIVE;

LOINC display name : ESBL by ceftazidime to ceftazidime-clavulanate IC ratio based on lab data Ql (Pos bld culture) [Interp];

LOINC long common name : ESBL by ceftazidime to ceftazidime-clavulanate IC ratio [Interpretation] by based on lab data in Positive blood culture Qualitative;

LOINC short name : ESBL cft to cft-clav IC rto Bd Pos Imp;

Détails

Origin ID

101583-3;

UMLS CUI

C5831053;

Has component
- Beta lactamase [LOINC component]
- Clavulanate [LOINC component]
- Concentration [LOINC component]
- ESBL by ceftazidime to ceftazidime-clavulanate IC ratio [LOINC component]
- cefTAZidime [LOINC component]
- cefTAZidime+Clavulanate [LOINC component]
Has method
- based on lab data [LOINC method]
Has property
- Impression/interpretation of study [LOINC Property]
Has scale
- Ord [LOINC scale]
Has system
- Blood [LOINC System]
- Positive blood culture [LOINC System]
Has time aspect
- Point in time (spot) [LOINC time aspect]
Semantic type(s)
- Clinical Attribute [UMLS semantic type]

Position du mot-clé dans l'(les) arborescence(s) :

Vous pouvez consulter :

recommendations
documents concerning education
documents for patients